HISTORY OF RESEARCH INTO MSS FROM AMSTERDAM UMC - UNIVERSITY OF OXFORD
Research into MSS is conducted in Oxford from a collaboration between Amsterdam UMC and University of Oxford. Having discovered in 2010 that an abnormality in the NFIX gene is the causative agent of Marshall-Smith Syndrome, this collaboration started in 2015.
We created a poster showing the timeline of the study and summarising in simple terms the results so far.
1 Kooblall, K.G., et al. (2023). A Mouse Model with a Frameshift Mutation in the Nuclear Factor I/X (NFIX) Gene Has Phenotypic Features of Marshall‐Smith Syndrome. JBMR Plus, 7(6): e10739. Link to article
2 Kooblall, K.G., et al. (2024). Identification of cellular retinoic acid binding protein 2 (CRABP2) as downstream target of nuclear factor I/X (NFIX): implications for skeletal dysplasia syndromes. JBMR Plus, 8(7): ziae060. Link to article


The MSS newsletters contain a lot of useful and practical information about (research on) Marshall-Smith syndrome. Several families also share their life stories. Read the most recent versions here.

On December 15, 2017 the MSS Research Foundation existed exactly 10 years. We are extremely grateful that the foundation has been able to do so much for children and adults with MSS and their families over the past 10 years. We celebrated this with a wonderful afternoon in CORPUS. Together we made a journey through man's body under the guidance of various experts in the field of MSS. We also looked back at what the foundation has been able to do for families with MSS in the past 10 years.
It is a next step in the efforts to strengthen the position of the patient and giving advice and information to families.The Dutch version is a result of efforts by Sonja Bracke and the Dutch umbrella organisation VSOP. The Fund PGO / Dutch Ministry of Health has funded this two-year program. The standards of care are available as an interactive pdf.